Tasly Pharmaceutical Group Co., Ltd (SHA:600535)
China flag China · Delayed Price · Currency is CNY
14.67
-0.11 (-0.74%)
Feb 13, 2026, 3:00 PM CST

SHA:600535 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
-2,9944,4513,1192,304
Trading Asset Securities
-524.72300.711,1251,487
Cash & Short-Term Investments
3,4893,5184,7514,2443,791
Cash Growth
-0.83%-25.95%11.95%11.95%78.94%
Accounts Receivable
-1,9662,1313,3483,796
Other Receivables
-23.0611.498.989.47
Receivables
-1,9892,1423,3573,805
Inventory
-1,7121,7481,5321,548
Other Current Assets
-91.7291.43127.08105
Total Current Assets
-7,3118,7339,2609,249
Property, Plant & Equipment
-3,6483,7693,8834,088
Long-Term Investments
-1,8212,0541,5111,229
Goodwill
--15.8815.88167.08
Other Intangible Assets
-604.17573.64459.43474.54
Long-Term Deferred Tax Assets
-53.175088.2960.79
Long-Term Deferred Charges
-1,4661,4761,1571,193
Other Long-Term Assets
-72.5443.14102.0879.68
Total Assets
-14,97616,71416,47716,542
Accounts Payable
-606.81572.73887.77728.58
Accrued Expenses
-171.05178.38242.79213.15
Short-Term Debt
-710.95814.63201.77188.79
Current Portion of Long-Term Debt
-586.83462.74475.21343.33
Current Portion of Leases
-47.8458.5453.9855.67
Current Income Taxes Payable
-57.7818.0484.62108.09
Current Unearned Revenue
-69.8591.6292.3568.33
Other Current Liabilities
-98.58172.88108.72149.12
Total Current Liabilities
-2,3502,3702,1471,855
Long-Term Debt
-253.761,4141,3761,034
Long-Term Leases
-67.9781.5275.3181.63
Long-Term Unearned Revenue
-193.29159.02177.79214.57
Long-Term Deferred Tax Liabilities
-0.40.1122.8742.18
Total Liabilities
-2,8654,0243,7993,228
Common Stock
-1,4941,5001,5001,513
Additional Paid-In Capital
-458.96958.081,4571,530
Retained Earnings
-9,8989,9299,35110,222
Treasury Stock
---105.98-105.98-251.29
Comprehensive Income & Other
-52.2288211.58-32.19
Total Common Equity
12,30411,90312,36812,41212,981
Minority Interest
-207.86321.59265.12332.56
Shareholders' Equity
12,50012,11112,69012,67813,314
Total Liabilities & Equity
-14,97616,71416,47716,542
Total Debt
857.031,6672,8312,1821,704
Net Cash (Debt)
2,6321,8511,9202,0622,088
Net Cash Growth
42.20%-3.59%-6.89%-1.23%-
Net Cash Per Share
1.761.241.291.401.39
Filing Date Shares Outstanding
1,4941,4941,4941,4941,499
Total Common Shares Outstanding
1,4941,4941,4941,4941,499
Working Capital
-4,9616,3637,1137,394
Book Value Per Share
8.247.978.288.318.66
Tangible Book Value
11,52511,29911,77911,93712,340
Tangible Book Value Per Share
7.717.567.887.998.23
Buildings
-3,5173,5053,4903,398
Machinery
-3,7633,6253,4723,340
Construction In Progress
-221.76153.87102.96167.85
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.